Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
Vaccination programs with the current prophylactic HPV vaccines started in most countries around 2008 with introduction of the bivalent Cervarix HPV16/18 vaccine, rapidly followed by Gardasil (HPV6/11/16/18) and, finally, Gardasil 9 (HPV6/11/16/18/31/33/45/52/58), from 2015. Many studies have now co...
Main Author: | Ian N. Hampson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/4/757 |
Similar Items
-
Differences on the prevalence of cervical HPV between Lithuania and Belarus
by: Gudleviciene Zivile, et al.
Published: (2014-04-01) -
Effect of HPV Vaccination on Virus Disappearance in Cervical Samples of a Cohort of HPV-Positive Polish Patients
by: Dominik Pruski, et al.
Published: (2023-12-01) -
State of HPV16 integration in Lithuanian women with cervical neoplasia
by: Sepetiene Agne, et al.
Published: (2011-04-01) -
Comment on “Will HPV vaccination prevent cervical cancer”
by: Shaokai Zhang, et al.
Published: (2020-04-01) -
HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico
by: Jorge Salmerón, et al.
Published: (2016-03-01)